The funding will help drugmakers establish new production lines and facilities and expand fill and finish capacity.
“This $3 billion investment in our vaccine supply chain will create thousands of good-paying American jobs, help us deliver on the president’s commitment to be the arsenal of vaccines for the world, and strengthen our long-term capabilities to respond to future threats,” White House COVID-19 response coordinator Jeff Zients said.
The companies receiving the funding have not been selected yet, but the contracting process will “start across the next several weeks,” according to Mr. Zients.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
